MOLECULAR EXPRESS, INC.

Basic Information

2011 E University Drive
RANCHO DOMINGUEZ, CA, 90220-6411

Company Profile

n/a

Additional Details

Field Value
DUNS: 58878682
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Engineering of a Novel CDN Nanoparticle Platform

    Amount: $245,943.00

    DESCRIPTION (provided by applicant): For many years, the use of protein and peptide antigens to induce specific immune responses has been an area of intense effort with the goal of developing improved ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Novel Hybrid Bioanalytical System

    Amount: $599,998.00

    DESCRIPTION (provided by applicant): Molecular Express specializes in the design and engineering of functionalized liposomes for drug delivery and vaccine development. In previous studies, an extensiv ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. A dual-nanopore platform for sensing and control of polynucleotides

    Amount: $294,301.00

    DESCRIPTION: In response to PA-10-150, we will test the hypothesis that the VesiVax(R) Conjugatable Adjuvant Lipid Vesicle (CALV) platform can provide an efficient method to develop carbohydrate conj ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. Development of a novel SP-B peptide lung surfactant

    Amount: $2,962,218.00

    DESCRIPTION (provided by applicant): This competitive renewal SBIR proposal extends our current Phase II translational research on novel synthetic lipid/peptide lung surfactants containing the highly ...

    SBIR Phase II 2012 Department of Health and Human Services
  5. Formulation of TLR 3, 7, and 8 Agonists in Conjugatable Adjuvant Lipid Vesicles

    Amount: $401,612.00

    DESCRIPTION (provided by applicant): The overall goal for this SHIFT SBIR application is to develop new, easy-to-use conjugatable adjuvant lipid vesicle (CALV) kits which contain Toll-like Receptor (T ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The overall goal of this SBIR AT application is to develop a multi-adjuvant liposomal vaccine formulation that targets dendritic cells and can be applied to our cu ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. Liposomal Nicotine Vaccine Development

    Amount: $344,800.00

    DESCRIPTION (provided by applicant): In response to RFA-DA-11-004, we propose in this STTR Phase I application to develop and test a nicotine vaccine utilizing a chemical derivative of the drug, or ha ...

    STTR Phase I 2011 Department of Health and Human Services
  8. Not Available

    Amount: $197,673.00

    The long term goal of this proposal is the development of a commercial point-of-care device capable of electronically sensing single circulating tumor cells (CTC) in the peripheral blood of a cancer p ...

    SBIR Phase I 2011 Department of Health and Human Services
  9. Surrogate endpoints for correlating protective immunity in response to influenza

    Amount: $599,994.00

    DESCRIPTION (provided by applicant): Influenza represents one of the most serious and common pandemic/epidemic viral diseases of human populations. Rapid mutations and rearrangements of the viral gen ...

    SBIR Phase I 2009 Department of Health and Human Services
  10. Production of a Lung Surfactant SP-B Mimic

    Amount: $1,210,420.00

    DESCRIPTION (provided by applicant): Surfactant Protein B (SP-B) is crucial in the function of native lung surfactant, and is equally important for activity in clinical exogenous surfactants as well. ...

    SBIR Phase II 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government